Bli medlem
Bli medlem

Du är här

2015-04-27

PRA Health Sciences: PRA is Named International Clinical Company of the Year

RALEIGH, N.C., April 27, 2015 (GLOBE NEWSWIRE) -- PRA Health Sciences (PRA) is pleased to announce that it was named Clinical Company of the Year at the International Clinical Researcher of the Year award ceremony in London. This is the second year in a row that PRA has won this prestigious award. PRA also swept the Clinical Team of the Year category. PRA winners include: * Clinical Research Associate: Charlotte Holmes
* Project Manager: Silvia Casellas
* Clinical Team Leader: Emma Lewis
* Clinical Team: Sarah Gage, Ashley King, Katy Mercer, Jo Perry

PRA was also recognized with five Silver awards and one Bronze.

"PRA is delighted to receive these awards," said Sean Leech, Executive Vice
President, PRA Health Sciences. "This recognition is a testament to the
caliber and talent of all our dedicated employees and we are immensely proud
of their accomplishments."

Organized byPharmaTimes
, the International Clinical Researcher of the Year competition is considered
a key barometer of quality standards in the clinical research industry. The
competition is judged by independent clinical research experts and is
designed to "recognize, encourage and inspire professionalism in tomorrow's
leaders."

In the 2015 competition PRA competed against finalists from 22 pharmaceutical
companies and clinical research organizations from around the world. The
Clinical Researcher of the Year Americas award ceremony is scheduled for June
4, 2015 in Raleigh, North Carolina. PRA is well represented with 17
finalists.

ABOUT PRA HEALTH SCIENCES

PRA Health Sciences is one of the world's leading global contract research
organizations, providing outsourced clinical development services to the
biotechnology and pharmaceutical industries. At PRA, providing innovative
solutions for our clients is what we do. Side-by-side with our clients, we
strive to move drug discovery forward, helping them to develop life-saving
and life-improving drugs. PRA has more than 11,000 employees working in 80+
countries providing comprehensive clinical development services across all
phases. From full service clinical development to the pioneering Embedded
Solutions(TM) model, PRA provides a broad spectrum of solutions that meet the
demands of a diverse marketplace. PRA has worked on 100+ marketed drugs
across several therapeutic areas and conducted the pivotal or supportive
trials that led to FDA and/or international regulatory approval of 50+ such
drugs.

CONTACT: MEDIA INQUIRIES:
Christine Rogers, Manager - Public Relations,
Corporate Communications
EMAIL: rogerschristine@prahs.com
PHONE: +1 919.786.8463
INVESTOR INQUIRIES:
InvestorRelations@prahs.com

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PRA Health Sciences via Globenewswire

HUG#1914965

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.